Results 141 to 150 of about 49,657 (223)

Association of nucleoside reverse transcriptase inhibitor use with reduced risk of Alzheimer's disease risk. [PDF]

Alzheimers Dement
Magagnoli J, Ambati M, Cummings TH, Nguyen J, Thomas CC, Ambati VL, Sutton SS, Gelfand BD, Ambati J.   +8 more
europepmc   +1 more source

Virtual screening, molecular docking studies and DFT calculations of FDA approved compounds similar to the non-nucleoside reverse transcriptase inhibitor (NNRTI) efavirenz. [PDF]

Heliyon, 2020
Jordaan MA, Ebenezer O, Damoyi N, Shapi M.   +3 more
europepmc   +1 more source

Synthesis, biological activity and docking study of imidazol-5-one as novel non-nucleoside HIV-1 reverse transcriptase inhibitors

, 2012
Santosh N. Mokale, Deepak K. Lokwani, Devanand B. Shinde   +2 more
openalex   +1 more source

Nucleoside Reverse Transcriptase Inhibitor (NRTI)-Induced Neuropathy and Mitochondrial Toxicity: Limitations of the Poly-γ Hypothesis and the Potential Roles of Autophagy and Drug Transport. [PDF]

Pharmaceutics
Haynes J, Joshi A, Larue RC, Eisenmann ED, Govindarajan R.   +4 more
europepmc   +1 more source

Synthesis and anti-HIV activities of urea-pETT analogs belonging to a new class of potent non-nucleoside HIV-1 Reverse transcriptase inhibitors

, 1998
Christer Sahlberg, Rolf Noréen, Per Engelhardt, Marita Högberg, Jussi Kangasmetsä, Lotta Vrang, Hong Zhang   +6 more
openalex   +1 more source

Spectrum of Non-Nucleoside Reverse Transcriptase Inhibitor-Associated Drug Resistance Mutations in Persons Living with HIV-1 Receiving Rilpivirine. [PDF]

Viruses
Nagarajan P, Zhou J, Di Teodoro G, Incardona F, Seguin-Devaux C, Kaiser R, Abecasis AB, Gomes P, Tao K, Zazzi M, Shafer RW, EuResist Network.   +11 more
europepmc   +1 more source

Brief Report: No Differences Between Lopinavir/Ritonavir and Nonnucleoside Reverse Transcriptase Inhibitor-Based Antiretroviral Therapy on Clearance of Plasmodium falciparum Subclinical Parasitemia in Adults Living With HIV Starting Treatment (A5297). [PDF]

J Acquir Immune Defic Syndr, 2022
Shaffer D, Kumwenda J, Chen H, Akelo V, Angira F, Kosgei J, Tonui R, Ssali F, McKhann A, Hogg E, Stewart VA, Murphy SC, Coombs R, Schooley R, A5297 Team.   +14 more
europepmc   +1 more source

Bioisosterism-driven design of orally active, safe, and broad-spectrum biphenyl-DAPY derivatives as highly potent HIV-1 non-nucleoside reverse transcriptase inhibitors

Xiaomei Chen, Qingqing Hao, Christophe Pannecouque, Erik De Clercq, Shuai Wang, Fen‐Er Chen   +5 more
openalex   +1 more source

In Silico Screening for Non‐nucleoside HIV‐1 Reverse Transcriptase Inhibitors Using Physicochemical Filters and High‐Throughput Docking Followed by In Vitro Evaluation

, 2009
Yasser Bustanji, Ihab M. Almasri, Ahmad Qasem, Amal G. Al‐Bakri, Mutasem O. Taha   +4 more
openalex   +1 more source

Fetal consequences of maternal antiretroviral nucleoside reverse transcriptase inhibitor use in human and nonhuman primate pregnancy

, 2015
Miriam C. Poirier, Alexander T. Gibbons, Marı́a Teresa Rugeles, Isabelle André‐Schmutz, Stéphane Blanche   +4 more
openalex   +1 more source